|
|
|
| home > white papers > Translating Cancer Genomics Into A Personalised Approach For Cancer Patients - PRA Health Sciences (PRA) |
|
|
 WHITE PAPERS |
|
PRA Health Sciences (PRA)
|
|
Translating Cancer Genomics Into A Personalised Approach For Cancer Patients
|
|
Over the past few decades, the approach to prevention, diagnosis and
treatment of cancer has radically shifted from organ-based to
morphology-based and most recently, to genetics-based. Personalized or
precision medicine (tailoring a treatment for a patient’s particular
disease at a precise time point) is being performed every day at
different levels in the clinical setting.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility
Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >> |
|
 |
White Papers |
 |
|
Wrap Around Label - A Lot of Content in a Small Space
Faubel & Co. Nachfolger GmbH
One of the world’s largest contract research organizations for the
planning and conducting of clinical trials was faced with the challenge
of accommodating many different national languages on an inhaler. The
inhaler was then to be distributed in 47 countries. Due to the impressive quality and
reliable collaboration, the organization commissioned Faubel with
finding the optimal labeling solution for the inhaler.
More info >> |
|
 |
Industry Events |
 |
Clinical Operations in Oncology Trials West Coast
17-18 November 2020, Hilton San Francisco Airport Bayfront
Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >> |
|
|
|
